Ulcerative colitis [UC] is a chronic inflammatory bowel disease [IBD] characterised by colonic...

An increased risk of adverse pregnancy and neonatal outcomes has been reported for pregnancies...

Attendees at UCD’s Charles Institute Seminar Series heard a presentation by Prof Xiaoli Wu on treatment...

The British Society for Rheumatology (BSR) has launched a new guideline for the treatment of psoriatic...

Results presented at the 2022 EULAR Congress show that early achievement of minimal...

Lupus nephritis (LN) is a frequent complication of systemic lupus erythematosus (SLE), and one...

Pain is an important consideration for people with rheumatic and musculoskeletal diseases (RMDs)...

Many different agents are available to treat people with axSpA, but they do not always work...

The use of a novel agent, sacituzumab govitecan, an antibody-drug conjugate, resulted...

Ibrutinib combined with bendamustine-rituximab improved PFS by 50 per cent for older patients with newly-diagnosed mantle...

The use of autologous stem cell transplant (ASCT) early in the course of treatment showed a...

The addition of nimotuzumab to gemcitabine increases OS in patients with KRAS wild-type advanced...